TP53 and neoplasm: This inhibitory effect of miR-339-5p on tumor growth was significantly less pronounced in HCT116 p53−/− tumors; the tumor volume was only reduced by ~2 fold in HCT116 p53−/− tumors (Figure 5A, B).